SCHEMBL22908313

SCHEMBL22908313

C#CCNS(=O)(=O)c1ccc(CCN(Cc2cc(Cl)ccc2OCCC)C(=O)Cc2ccsc2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29567130 1.00
SCHEMBL22908297 0.96
SCHEMBL29694522 0.96
SCHEMBL22908302 0.96
SCHEMBL22908296 0.91
SCHEMBL22908303 0.91
SCHEMBL22908306 0.91
SCHEMBL22908329 0.89 NLRP3 (0.72)
SCHEMBL22908308 0.89 NLRP3 (0.78)
SCHEMBL22908295 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12221406-B2 Compounds as NLRP3 inflammasome inhibitors and compositions and uses thereof VIRGINIA COMMONWEALTH UNIVERSITY (US) 2025-02-11 US disclosed
US-20220259144-A1 COMPOUNDS AS NLRP3 INFLAMMASOME INHIBITORS AND COMPOSITIONS AND USES THEREOF VIRGINIA COMMONWEALTH UNIVERSITY 2022-08-18 US disclosed
EP-3999045-A1 COMPOUNDS AS NLRP3 INFLAMMASOME INHIBITORS AND COMPOSITIONS AND USES THEREOF Virginia Commonwealth University (US) 2022-05-25 EP disclosed
WO-2021011592-A1 COMPOUNDS AS NLRP3 INFLAMMASOME INHIBITORS AND COMPOSITIONS AND USES THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 2021-01-21 WO disclosed